Ariane Vieira Scarlatelli Macedo
Publications by Year
Research Areas
Chemotherapy-induced cardiotoxicity and mitigation, COVID-19 Clinical Research Studies, Cancer Treatment and Pharmacology, Venous Thromboembolism Diagnosis and Management, Long-Term Effects of COVID-19
Most-Cited Works
- → Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society(2020)735 cited
- → Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial(2021)490 cited
- → Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19(2021)379 cited
- → Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer(2019)159 cited
- → Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial(2020)144 cited
- → Diretriz Brasileira de Cardio-oncologia – 2020(2020)91 cited
- → Advances in the Treatment of Cardiac Amyloidosis(2020)64 cited
- → Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy(2020)55 cited
- → Drug–Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms(2020)39 cited
- → IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial(2021)35 cited